The other is a sophisticated regulator, fine-tuning the body's complex metabolic orchestra
More than 400 million people worldwide have T2DM [3], and its incidence increases as the population ages, obesity increases, and urbanization progresses [4,5,6,7]
In clinical studies, injection site reactions were reported in approximately 3-4% of patients receiving tirzepatide
I was having a significant problem with my bowels (nausea mostly) and stomach aches, and day long headaches
"The Brighton Criteria for JHS"
In this study, however, one-third of the involved population remained with the starting dose of 3 mg despite the recommendation reported in the summary of product characteristics and only 16% reached the maintenance dose of 14 mg [28]